5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 34.98▼ | 34.88▲ | 34.95▼ | 36.09▼ | 36.67▼ |
MA10 | 34.95▼ | 34.99▼ | 34.96▼ | 36.58▼ | 33.62▲ |
MA20 | 34.89▲ | 34.97▼ | 35.33▼ | 37.11▼ | 33.69▲ |
MA50 | 34.97▼ | 35.68▼ | 35.87▼ | 33.37▲ | 28.34▲ |
MA100 | 35.01▼ | 35.95▼ | 37.93▼ | 33.13▲ | 25.10▲ |
MA200 | 35.29▼ | 37.94▼ | 35.39▼ | 29.81▲ | 35.96▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.017▲ | 0.035▲ | 0.015▲ | -0.611▼ | 0.082▲ |
RSI | 50.315▲ | 42.716▼ | 39.160▼ | 47.867▼ | 55.352▲ |
STOCH | 72.447 | 16.725▼ | 22.905 | 18.917▼ | 57.766 |
WILL %R | -40.000 | -82.955▼ | -81.564▼ | -94.667▼ | -46.617 |
CCI | 40.891 | -34.865 | -22.736 | -76.722 | 56.883 |
Monday, June 30, 2025 09:53 AM
Amgen's Phase 3 trial of bemarituzumab plus chemo met its survival goal in FGFR2b+ gastric cancer, with full data expected later.
|
Monday, June 30, 2025 08:00 AM
Amgen (NASDAQ:AMGN) and Zai Lab (NASDAQ:ZLAB) said on Monday that a late-stage trial testing the combination of bemarituzumab and chemotherapy for treating gastric cancer has successfully met its main ...
|
Friday, June 27, 2025 01:00 PM
Zai Lab Limited (NASDAQ:ZLAB) is one of the 10 biotech stocks screaming a buy. On June 17, the company delivered positive trial results from a preclinical study of ZL-1503, a promising IL-13/IL ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/06/25 | 36.40 | 36.73 | 34.55 | 34.97 | 847,124 |
27/06/25 | 35.26 | 35.50 | 34.57 | 34.74 | 755,497 |
26/06/25 | 36.87 | 36.87 | 35.91 | 36.19 | 559,857 |
25/06/25 | 37.07 | 37.10 | 35.955 | 36.96 | 761,135 |
24/06/25 | 37.57 | 38.18 | 37.29 | 37.58 | 780,726 |
23/06/25 | 35.56 | 36.405 | 35.125 | 36.01 | 747,988 |
20/06/25 | 35.67 | 35.76 | 34.4421 | 34.55 | 1,079,257 |
18/06/25 | 37.45 | 37.65 | 36.79 | 36.93 | 662,128 |
17/06/25 | 38.38 | 38.51 | 36.3601 | 37.22 | 1,224,341 |
16/06/25 | 40.705 | 41.185 | 39.95 | 40.63 | 669,026 |
|
|
||||
|
|
||||
|
|